/Companies

Glaukos

NYSE: GKOS

Aliso Viejo, US · Founded 1998 · 1,150 employees on LinkedIn · 2 known investors

Find your way into Glaukos

Sign up to see every warm intro you have to Glaukos

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Glaukos team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Glaukos develops micro-scale medical devices and pharmaceuticals for treating glaucoma, corneal disorders, and retinal diseases, replacing traditional drop therapies with minimally invasive surgery platforms. Founded in 1998 and publicly traded on the NYSE, the company serves ophthalmology patients globally.

Founders & leadership

TW
Thomas W. BurnsChief Executive Officer and Chairman of the Board

Investors · 2

Related companies · 5

Companies working in the same space as Glaukos.

Frequently asked questions

What does Glaukos do?
Glaukos develops micro-scale medical devices and pharmaceuticals for treating glaucoma, corneal disorders, and retinal diseases, replacing traditional drop therapies with minimally invasive surgery platforms. Founded in 1998 and publicly traded on the NYSE, the company serves ophthalmology patients globally.
Who are Glaukos's investors?
Glaukos's investors include Avedro, Inc., Montreux Equity Partners.
Where is Glaukos headquartered?
Glaukos is headquartered in Aliso Viejo, US.